Comparative Safety and Tolerability of Angiotensin II Receptor Antagonists
- 1 January 1999
- journal article
- research article
- Published by Springer Nature in Drug Safety
- Vol. 21 (1) , 23-33
- https://doi.org/10.2165/00002018-199921010-00003
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Pharmacokinetics of valsartan in patients with liver diseaseClinical Pharmacology & Therapeutics, 1997
- Angiotensin II receptor antagonists - antihypertensive agentsExpert Opinion on Investigational Drugs, 1997
- Renal Impairment Associated with LosartanAnnals of Internal Medicine, 1996
- Global efficacy and tolerability of losartan, an angiotensin II subtype 1-receptor antagonist, in the treatment of hypertension.1996
- Drug induced acute pancreatitis: incidence and severity.Gut, 1995
- The angiotensin II type 1 receptor antagonists. A new class of antihypertensive drugs.1995
- Effects of Losartan on a Background of Hydrochlorothiazide in Patients With HypertensionHypertension, 1995
- Losartan in Heart FailureCirculation, 1995
- Is the antiproteinuric effect of ACE inhibition mediated by intereference in the renin-angiotensin system?Kidney International, 1994
- Cough and Angioneurotic Edema Associated with Angiotensin-Converting Enzyme Inhibitor TherapyAnnals of Internal Medicine, 1992